Improved human islet isolation using nicotinamide

American Journal of Transplantation

Volumn 6, Issue 9, 2006, Pages 2060-2068

  Ichii, H ^a,b   Wang, X ^a   Messinger, S ^a   Alvarez, A ^a   Fraker, C ^a   Khan, A ^a   Kuroda, Y ^b   Inverardi, L ^a   Goss, J A ^c   Alejandro, R ^a   Ricordi, C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b KOBE UNIVERSITY   (Japan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Islet; Isolation; Nicotinamide; Transplantation; Two layer method

Indexed keywords

INSULIN; NICOTINAMIDE;

ADULT; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PANCREAS FUNCTION; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TISSUE PREPARATION; TISSUE PRESERVATION; TWO LAYER METHOD;

ADENOSINE; ADULT; ALLOPURINOL; CELL SEPARATION; DIABETES MELLITUS, TYPE 1; GLUTATHIONE; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MIDDLE AGED; NIACINAMIDE; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PANCREAS; RAFFINOSE; RETROSPECTIVE STUDIES;

EID: 33746930848     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01452.x     Document Type: Article

References (44)

1. Ricordi C, Strom TB. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol 2004; 4: 259-268.
2. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
3. Hering BJ, Kandaswamy R, Ansite JD et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830-835.
4. Froud T, Ricordi C, Baidal DA et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037-2046.
5. Rose NL, Palcic MM, Helms LM, Lakey JR. Evaluation of Pefabloc as a serine protease inhibitor during human-islet isolation. Transplantation 2003; 75: 462-466.
6. Matsumoto S, Rigley TH, Reems JA, Kuroda Y, Stevens RB. Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant 2003; 3: 53-63.
7. Sawada T, Matsumoto I, Nakano M, Kirchhof N, Sutherland DE, Hering BJ. Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation. Transplantation 2003; 75: 1965-1969.
8. Ichii H, Pileggi A, Molano RD et al. Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant 2005; 5: 21-30.
9. Markmann JF, Deng S, Huang X et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003; 237: 741-750.
10. Mandrup-Poulsen T, Reimers JI, Andersen HU et al. Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus. Diabetes Metab Rev 1993; 9: 295-309.
11. Hoorens A, Pipeleers D. Nicotinamide protects human beta cells against chemically-induced necrosis, but not against cytokine-induced apoptosis. Diabetologia 1999; 42: 55-59.
12. Eizirik DL, Sandler S, Welsh N, Bendtzen K, Hellerstrom C. Nicotinamide decreases nitric oxide production and partially protects human pancreatic islets against the suppressive effects of combinations of cytokines. Autoimmunity 1994; 19: 193-198.
13. Andersen HU, Jorgensen KH, Egeberg J, Mandrup-Poulsen T, Nerup J. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 1994; 43: 770-777.
14. Goto M, Eich TM, Felldin M et al. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 2004; 15; 78: 1367-1375.
15. Moberg L, Johansson H, Lukinius A et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360: 2039-2045.
16. Johansson H, Lukinius A, Moberg L et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005; 54: 1755-1762.
17. Piemonti L, Leone BE, Nano R et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 2002; 51: 55.
18. Bertuzzi F, Marzorati S, Maffi P et al. Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type 1 diabetic recipients. J Clin Endocrinol Metab 2004; 89: 5724-5728.
19. Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and interleukin-1 beta-exposed human and rat islet cells. Diabetologia 2001; 44: 325-332.
20. Moberg L, Olsson A, Berne C et al. Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation 2003 Nov 15; 76: 1285-1288.
21. Kuroda Y, Kawamura T, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation 1988; 46: 457-60.
22. Kuroda Y, Fujino Y, Morita A, Tanioka Y, Ku Y, Saitoh Y. The mechanism of action of the two-layer (Euro-Collins' solution/ perfluorochemical) cold-storage method in canine pancreas preservation - the effect of 2,4 dinitrophenol on graft viability and adenosine triphosphate tissue concentration. Transplantation 1992; 53: 992-994.
23. Matsumoto S, Kuroda Y, Hamano M et al. Direct evidence of pancreatic tissue oxygenation during preservation by the two-layer method. Transplantation 1996; 62: 1667-1670.
24. Tanioka Y, Kuroda Y, Kim Y et al. The effect of ouabain (inhibitor of an ATP-dependent Na+/K+ pump) on the pancreas graft during preservation by the two-layer method. Transplantation 1996; 62: 1730-1734.
25. Matsumoto S, Qualley SA, Goel S et al. Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 2002; 74: 1414-1419.
26. Tsujimura T, Kuroda Y, Avila JG et al. Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method. Transplantation 2004; 78: 96-100.
27. Ricordi C, Fraker C, Szust J et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003; 75: 1524-1527.
28. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413-420.
29. Ranuncoli A, Cautero N, Ricordi C et al. Islet cell transplantation: in vivo and in vitro functional assessment of nonhuman primate pancreatic islets. Cell Transplant 2000; 9: 409-414.
30. Ichii H, Inverardi L, Pileggi A et al. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 2005; 5: 1635-1645.
31. Alejandro R, Strasser S, Zucker PF, Mintz DH. Isolation of pancreatic islets from dogs. Semiautomated purification on albumin gradients. Transplantation 1990; 50: 207-210.
32. LeDoux SP, Hall CR, Forbes PM, Patton NJ, Wilson GL. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity. Diabetes 1988; 37: 1015-1019.
33. Hauschildt S, Scheipers P, Bessler WG. Inhibitors of poly (ADP-ribose) polymerase suppress lipopolysaccharide-induced nitrite formation in macrophages. Biochem Biophys Res Commun 1991; 179: 865-871.
34. Mandrup-Poulsen T, Reimers JI, Andersen HU et al. Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus. Diabetes Metab Rev 1993; 9: 295-309.
35. Ricordi C. Islet transplantation: a brave new world. Diabetes 2003; 52: 1595-1603.
36. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997; 46: 1120-1123.
37. Bottino R, Balamurugan AN, Tse H et al. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004; 53: 2559-2568.
38. Aikin R, Rosenberg L, Paraskevas S, Maysinger D. Inhibition of caspase-mediated PARP-1 cleavage results in increased necrosis in isolated islets of Langerhans. J Mol Med 2004; 82: 389-397.
39. London NJM, James RFL, Bell PRF. Islet purification. In: Ricordi C, ed. Pancreatic Islet Cell Transplantation. Austin, TX: Landes, 1992: 113-123.
40. Fujino Y, Suzuki Y, Tsujimura T et al. Possible role of heat shock protein 60 in reducing ischemic-reperfusion injury in canine pancreas grafts after preservation by the two-layer method. Pancreas 2001; 23: 393-398.
41. Heard SO, Puyana JC. The anti-inflammatory effects of perfluorocarbons: let's get physical. Crit Care Med 2000; 28: 1241-1242.
42. Bekyarova G, Yankova T, Galunska B. Increased antioxidant capacity, suppression of free radical damage and erythrocyte aggrerability after combined application of alpha-tocopherol and FC-43 perfluorocarbon emulsion in early postburn period in rats. Artif Cells Blood Substit Immobil Biotechnol 1996; 24: 629-641.
43. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 1991; 174: 1517-1526.
44. Ueda A, Okuda K, Ohno S et al. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994; 153: 2052-2063.